379
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
this post was submitted on 09 Aug 2023
379 points (100.0% liked)
Technology
37801 readers
320 users here now
A nice place to discuss rumors, happenings, innovations, and challenges in the technology sphere. We also welcome discussions on the intersections of technology and society. If it’s technological news or discussion of technology, it probably belongs here.
Remember the overriding ethos on Beehaw: Be(e) Nice. Each user you encounter here is a person, and should be treated with kindness (even if they’re wrong, or use a Linux distro you don’t like). Personal attacks will not be tolerated.
Subcommunities on Beehaw:
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
That's more of a US problem than it is a pharmaceutical patents problem.
Only they are able to benefit from that research at first. Which is how it's always been, new things are rare and expensive at first and become cheaper and more common over time.
But that rarity is entirely manufactured.